Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Agile Therapeutics, Inc. AGRX NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
31/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.00
-33.8%

Agile Therapeutics, Inc. (AGRX) has 12 identified peers for comparison in the Healthcare sector. Peers include ACRX, AMRX, AQST, ASRT, ATNX, CPIX and others.

AGRX has a market capitalization of $10.43M, compared to an average peer market cap of $413.41M. AGRX is notably smaller than its average peer.

People Also View

AMRX
AMRX
Amneal Pharmaceuticals, Inc.
$13.05
-0.53%
 AQST
AQST
Aquestive Therapeutics, Inc.
$4.24
+2.17%
 LFCR
LFCR
Lifecore Biomedical, Inc.
$5.38
+3.46%
 TKNO
TKNO
Alpha Teknova, Inc.
$2.74
-9.57%
 ASRT
ASRT
Assertio Holdings, Inc.
$18.02
+0.00%
 CPIX
CPIX
Cumberland Pharmaceuticals Inc.
$3.20
+0.63%
 CYTH
CYTH
Cyclo Therapeutics, Inc.
$0.72
+0.00%
 EVOK
EVOK
Evoke Pharma, Inc.
$11.00
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message